04:08:28 EST Fri 12 Dec 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

C:INNO - InnoCan Pharma Corporation - Common Shares - https://innocanpharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
INNO - C  0.19.55·11.030.39.91-0.89-8.20.2139.91  9.91  9.9121.00  7.00Dec 11Dec 1015 min RT 2¢
CSE - C0.19.55·11.030.39.91-0.89-8.20.1119.91  9.91  9.9121.00  7.00Dec 1115 min
CXD - D 10.800.0011    Oct 3115 min
MatchNOW - M 10.800.0511    Aug 12-2015 min

Recent Trades - All 3 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-12-10 19:20C:INNO10.80News ReleaseInnocan files amendment for U.S. public offering
2025-11-27 01:34C:INNO12.00News ReleaseInnocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M
2025-11-26 16:45C:INNO12.00SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-26 16:45C:INNO12.00SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-24 20:57C:INNO12.79News ReleaseInnocan notes article on LPT-CBD injections in goats
2025-10-15 19:55C:INNO16.00News ReleaseInnocan receives LPT-CBD patent allowance in Japan
2025-09-18 20:27C:INNO11.00News ReleaseInnocan's LPT-CBD injection in use at Freedom Farm
2025-09-15 16:01C:INNO12.00News ReleaseInnocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference
2025-09-02 17:01C:INNO0.22RollbackInnocan Pharma 1:65 rollback
2025-09-02 13:49C:INNO0.21News ReleaseCSE Bulletin: Consolidation - InnoCan Pharma Corporation (INNO)
2025-08-29 17:58C:INNO0.21News ReleaseInnocan to roll back shares one for 65
2025-08-22 16:00C:INNO0.21News ReleaseInnocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada
2025-07-23 21:26C:INNO0.21News ReleaseInnocan Pharma files registration statement on Form F-1
2025-07-03 19:25C:INNO0.24News ReleaseInnocan Pharma executive chairman Mayron resigns
2025-05-28 18:35C:INNO0.16News ReleaseInnocan has $500,000 (U.S.) operating profit in Q1 2025
2025-05-28 16:49C:INNO0.16SEDAR Interim MD & ASEDAR Interim MD & A
2025-05-28 16:43C:INNO0.16SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-05-06 05:05C:INNO0.16News ReleaseInnocan receives Mexican patent for topical pain relief
2025-04-07 18:35C:INNO0.16News ReleaseInnocan files application for Chinese CBD tech patent
2025-03-31 06:02C:INNO0.205SEDAR MD & ASEDAR MD & A